{
  "resourceType": "Bundle",
  "type": "collection",
  "entry": [
    {
      "resource": {
        "resourceType": "CarePlan",
        "id": "c8d10b1a-2e3f-4c5d-6a7b-8e9f0a1b2c3d",
        "status": "draft",
        "intent": "plan",
        "note": [
          {
            "text": "Missing renal function labs preclude safe contrast administration."
          },
          {
            "text": "PE is a strong clinical indication for CTA given the patient's symptoms."
          },
          {
            "text": "Alternative non-contrast imaging is necessary for significant renal impairment."
          },
          {
            "text": "Low-dose CT screening criteria are not met for this patient."
          }
        ],
        "activity": [
          {
            "detail": {
              "kind": "ServiceRequest",
              "description": "STAT serum creatinine, BUN, and electrolytes (including potassium) are required to calculate eGFR before any contrast administration."
            }
          },
          {
            "detail": {
              "kind": "ServiceRequest",
              "description": "If eGFR is sufficient (>= 45 mL/min/1.73m²), proceed with CT Pulmonary Angiography (CT_CHEST_ANGIO_PULMONARY_EMBOLISM) with weight-based low-osmolar iodinated contrast."
            }
          },
          {
            "detail": {
              "kind": "ServiceRequest",
              "description": "If eGFR is < 30 mL/min/1.73m², avoid iodinated contrast and consider a ventilation-perfusion (V/Q) scan or MR pulmonary angiography."
            }
          },
          {
            "detail": {
              "kind": "ServiceRequest",
              "description": "Re-evaluate the indication for low-dose CT chest screening; it is not currently indicated based on available patient data."
            }
          }
        ]
      }
    },
    {
      "resource": {
        "resourceType": "PlanDefinition",
        "id": "p1a9b8c7-d6e5-4f3a-2b1c-0d9e8f7a6b5c",
        "identifier": [
          {
            "system": "http://example.org/fhir/protocol-ids",
            "value": "CT_CHEST_ANGIO_PULMONARY_EMBOLISM"
          }
        ],
        "title": "CT Pulmonary Angiography (Chest CTA for PE)",
        "status": "draft",
        "type": {
          "coding": [
            {
              "system": "http://terminology.hl7.org/CodeSystem/plan-definition-type",
              "code": "protocol",
              "display": "Protocol"
            }
          ]
        },
        "description": "CT angiography timed for pulmonary arterial phase (6–13 sec post-contrast) to evaluate pulmonary arteries for embolism.",
        "topic": [
          {
            "coding": [
              {
                "display": "pulmonary embolism"
              }
            ]
          },
          {
            "coding": [
              {
                "display": "acute chest pain"
              }
            ]
          },
          {
            "coding": [
              {
                "display": "shortness of breath"
              }
            ]
          }
        ],
        "action": [
          {
            "description": "Perform CT Pulmonary Angiography. Contrast timing: Pulmonary arterial phase: ~6–13 sec post-injection. Contrast dose: Weight-based; ~100–150 mL iodinated contrast (300 mg I/mL); follow ACR Manual. Renal safety notes: Ensure contrast-to-eGFR ratio <1.1 g/(mL/min); if eGFR <30, consider non-contrast alternatives or weigh risks carefully."
          }
        ],
        "relatedArtifact": [
          {
            "type": "documentation",
            "display": "Contrast CT phases overview (Wikipedia)"
          },
          {
            "type": "documentation",
            "display": "CT pulmonary angiogram practical notes (Wikipedia)"
          }
        ]
      }
    },
    {
      "resource": {
        "resourceType": "PlanDefinition",
        "id": "p2c3d4e5-f6a7-8b9c-0d1e-2f3a4b5c6d7e",
        "identifier": [
          {
            "system": "http://example.org/fhir/protocol-ids",
            "value": "CT_CHEST_LOW_DOSE_SCREENING"
          }
        ],
        "title": "Low-Dose CT Chest – Lung Cancer Screening",
        "status": "draft",
        "type": {
          "coding": [
            {
              "system": "http://terminology.hl7.org/CodeSystem/plan-definition-type",
              "code": "protocol",
              "display": "Protocol"
            }
          ]
        },
        "description": "Low-dose CT of lungs targeting <3 mGy radiation dose while maintaining image quality.",
        "topic": [
          {
            "coding": [
              {
                "display": "lung cancer screening"
              }
            ]
          },
          {
            "coding": [
              {
                "display": "high-risk cohorts"
              }
            ]
          }
        ],
        "action": [
          {
            "description": "Perform Low-Dose CT Chest – Lung Cancer Screening. Contrast timing: N/A – non-contrast low-dose protocol. Contrast dose: None. Renal safety notes: Ideal in patients with renal dysfunction due to non-use of contrast."
          }
        ],
        "relatedArtifact": [
          {
            "type": "documentation",
            "display": "Low-dose CT screening dose benchmarks PMC"
          }
        ]
      }
    }
  ]
}